Discreet and confidential delivery
200,000+ trusted patients
10,364 Reviews on TrustPilot
Excellent
Free online consultation
10,000+ 5* reviews
Wegovy Tablets UK Oral Semaglutide Weight Loss Pills
10,364 reviews
Wegovy Tablets UK Oral Semaglutide Weight Loss Pills
Can you buy Wegovy tablets in the UK?
You cannot currently buy Wegovy tablets in the UK because oral Wegovy has not yet been approved by the MHRA. Wegovy is currently available in the UK as an injection only.
When Wegovy tablets are approved in the UK, Chemist Click will offer them through a regulated online consultation, subject to clinical suitability and prescription approval.
Summary for Wegovy Tablets
| Medication Class | GLP-1 receptor agonist |
|---|---|
| Mechanism of action | Mimics the natural hormone GLP-1 to reduce appetite, increase feelings of fullness, slow gastric emptying, and improve glucose regulation. |
| Active ingredient | Semaglutide |
| Strength | 1.5mg, 4mg, 9mg and 25mg tablets |
| Dosage instructions | Take one tablet daily |
| Effective within | 1-2 weeks: Appetite reduction 4-8 weeks: Noticeable weight loss 3-6 months onwards: Peak clinical effect |
| Results | On average, up to 17% |
| Manufacturer | Novo Nordisk |
| Use with alcohol | In moderation |
About Wegovy Tablets
What are Wegovy tablets?
Wegovy tablets are an oral form of semaglutide designed to support weight loss. They contain the same active ingredient as Wegovy injections, but are taken by mouth instead of injected.
They are taken once daily and work by reducing appetite, increasing feelings of fullness and helping you eat fewer calories over time.
This makes them a potential needle-free alternative for people who want the benefits of semaglutide weight loss treatment without using injections.
How do Wegovy tablets work?
Wegovy tablets contain semaglutide, a GLP-1 receptor agonist.
They work by:
- Reducing appetite and increasing feelings of fullness
- Slowing stomach emptying, helping you stay satisfied for longer
- Lowering cravings and caloric intake
- Improving blood-sugar control and insulin sensitivity
An oral (tablet) form delivers semaglutide through the digestive system using absorption-enhancing technology so that enough medication enters the bloodstream to produce the same appetite-regulating effects as weight loss injections.
Wegovy tablets results
Key findings from late-stage studies (e.g., OASIS trials):
- Participants taking oral semaglutide achieved average weight loss of 16.6% of body weight over approximately 68 weeks.
- A third of participants lost 20% or more of their starting weight, within the same trial
- A substantial proportion of patients achieved between 10-15% weight loss, levels associated with meaningful health benefits.
- Appetite reduction and improved portion control were observed early, with progressive weight loss over time.
Further reading: Wegovy tablets results
Wegovy tablets produced weight loss similar to standard Wegovy 2.4mg injections in clinical trial comparisons, although higher-dose injectable Wegovy may produce greater average weight loss.
Are Wegovy tablets safe?
Wegovy tablets contain oral semaglutide, the same active ingredient as Wegovy injections. Clinical trials suggest they have a safety profile broadly similar to injectable Wegovy, with the most common side effects being nausea, vomiting, constipation and diarrhoea.
Most digestive side effects were mild to moderate and improved over time, but Wegovy tablets are not suitable for everyone and should only be used after a clinical assessment.
Wegovy tablets vs injections
| Feature | Wegovy Injections | Wegovy Tablets (Oral Semaglutide) |
|---|---|---|
| Form | Once-weekly injection | Daily tablet |
| Availability | Approved and available in the UK | Not yet approved in the UK |
| Effectiveness | Around 15% average weight loss with standard 2.4mg dosing; higher-dose Wegovy injections may produce more. | Around 17% average weight loss in trials |
| Convenience | Weekly dosing, requires injection | No needles; taken by mouth |
| Onset & consistency | Highly reliable absorption | Absorption can be more variable |
| Side-effect profile | Similar GLP-1 effects (nausea, GI symptoms) | Similar GLP-1 effects |
Further reading: Wegovy tablets vs injections
How much will Wegovy tablets cost in the UK?
The price of Wegovy tablets in the UK has not yet been confirmed, as they are not currently approved or available to buy in the UK.
However, Wegovy tablets may be cheaper than Wegovy injections if UK pricing follows the same pattern seen in the US.
Until an official UK launch and price are announced, any estimate should be treated as speculative.
When will Wegovy tablets be available in the UK?
There is no confirmed UK launch date for Wegovy tablets. They have been approved in the US, but they are not yet approved by the MHRA in the UK.
Some estimates suggest late 2026 or 2027, but this has not been confirmed.
Join our waitlist to be the first to find out when Wegovy tablets are available to buy.
Wegovy tablets dosage
| Treatment Phase | Time Period | Dose | Schedule |
|---|---|---|---|
| Starter Dose | Month 1 | 1.5mg | Once daily |
| Titration 1 | Month 2 | 4mg | Once daily |
| Titration 2 | Month 3 | 9mg | Once daily |
| Maintenance | Month 4 onwards | 25mg | Once daily |
- You begin on a low dose to minimise stomach upset.
- The dose is gradually increased over the first three months. Your prescriber may wish to keep you at one dose for longer than a month to allow your body more time to adjust.
- From month four, you stay on a maintenance dose designed to give the best balance of appetite control and weight loss.
- Tablets would typically be taken once daily, often on an empty stomach with water, to ensure proper absorption.
Further reading: Wegovy tablets dosage
*Oral semaglutide not currently licensed or approved in the United Kingdom by the MHRA. The dosing schedule above is based on US prescribing data.
Side effects of Wegovy tablets
Side effects are expected to be similar to injectable semaglutide and other GLP-1 medicines:
Common:
- Nausea
- Vomiting
- Diarrhoea or constipation
- Abdominal discomfort
- Reduced appetite
Less common but important:
- Dehydration (secondary to vomiting/diarrhoea)
- Gallbladder issues with rapid weight loss
- Rare pancreatitis
Most gastrointestinal symptoms are mild to moderate and improve as the body adapts.
Further reading: Wegovy tablets side effects
Wegovy tablet warnings
Wegovy tablets are not suitable for:
- Individuals with a personal or family history of medullary thyroid carcinoma or MEN2
- An allergy to semaglutide
Caution should be taken in people with:
- Severe gastrointestinal disease
- Type 2 diabetes
- A history of diabetic retinopathy
- A history of mental health concerns
- An upcoming surgery where sedation is going to be used
Wegovy tablet interactions
Potential interactions are expected to mirror injectable semaglutide:
- Diabetes medications (e.g., insulin, sulfonylureas) may increase the risk of low blood sugar.
- Medications requiring rapid absorption may be affected because GLP-1 medicines slow gastric emptying.
Pregnancy and breastfeeding
- Oral Wegovy tablets are not recommended in pregnancy. Weight-loss medicines should be stopped if you are pregnant or planning pregnancy.
- Oral Wegovy tablets are not recommended while breastfeeding. There is insufficient safety data regarding exposure to infants.
Frequently Asked Questions
No. Wegovy tablets are not currently available in the UK. Wegovy is available in the UK as an injection, but the tablet form of Wegovy has not yet been approved by the MHRA.
Wegovy tablets have been approved in the US, but they cannot be prescribed or supplied in the UK until UK regulatory approval is granted.
No. You cannot legally buy Wegovy tablets online in the UK at the moment because they are not currently approved or available here.
If you see websites, marketplaces or social media sellers offering Wegovy tablets in the UK, you should be cautious, as these products may be unlicensed, unsafe or counterfeit.
No. Wegovy tablets have not currently been approved by the MHRA. The US FDA approved Wegovy tablets in December 2025, but UK approval has not yet been confirmed.
Until the MHRA approves Wegovy tablets, they cannot be legally supplied as a licensed weight loss treatment in the UK.
There is no confirmed UK launch date for Wegovy tablets.
Some estimates suggest they could become available in late 2026 or 2027 if MHRA approval is granted, but this has not been officially confirmed. For now, Wegovy remains available in the UK as an injection rather than a tablet.
The UK price of Wegovy tablets has not been confirmed because they are not yet available in the UK.
However, they may be cheaper than Wegovy injections if UK pricing follows the US model, where oral Wegovy launched at a cheaper price than injectable weight loss treatments.
Final UK pricing will depend on approval, supply, dose and pharmacy pricing.
Yes. Wegovy tablets are a form of oral semaglutide.
Semaglutide is the active ingredient in Wegovy, and the tablet version is designed to be taken by mouth rather than injected. It works by mimicking the GLP-1 hormone, helping reduce appetite, increase fullness and support weight loss.
No. Wegovy tablets and Rybelsus both contain oral semaglutide, but they are not the same treatment.
Rybelsus is licensed for type 2 diabetes, not weight loss, and is available in lower doses.
Wegovy tablets are higher-dose oral semaglutide tablets developed specifically for weight management in countries where they are approved.
Wegovy tablets contain oral semaglutide, while orforglipron is a different oral GLP-1 tablet being developed by Eli Lilly.
Both are tablets designed to support weight loss, but they contain different active ingredients.
Wegovy tablets appear to offer weight loss results broadly comparable with standard Wegovy 2.4mg injections, although they have not been directly compared in a head-to-head UK trial.
In the OASIS 4 trial, Wegovy tablets produced average weight loss of 16.6% in people who stayed on treatment. However, higher-dose Wegovy injections may produce greater average weight loss in some patients.
In the OASIS 4 trial, people taking Wegovy tablets lost an average of 16.6% of their body weight when they stayed on treatment.
Around one in three people lost 20% or more of their body weight. Individual results can vary depending on dose, diet, activity levels, side effects, treatment adherence and starting weight.
Yes. If Wegovy tablets are approved in the UK, they will require a prescription.
They should only be supplied after a clinical consultation to check whether treatment is suitable and safe. You should not buy Wegovy tablets from unregulated websites, social media sellers or marketplaces.
You can join the Wegovy tablets waiting list by entering your details on the Chemist Click Wegovy tablets page.
We will let you know when Wegovy tablets become available in the UK. Treatment will only be supplied if Wegovy tablets are approved in the UK and are clinically suitable for you after an online consultation.
- UK registered online pharmacy
- Pharmacist-led weight loss service
- Regulated prescription process
- Clinical suitability checks
- Ongoing weight loss support
- Discreet delivery
- Verified reviews
- No unlicensed or counterfeit medicines
Superintendent Pharmacist
Written by Chemist Click
First created 7th May 2026
Last reviewed 18th May 2026
